Atlas Trials

Residual Disease

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Residual Disease

RecordFirmDate
Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer (NCT04674306)George T. Budd2021-10-01
R0 Resection Rate Between CSP, cEMR and hEMR for 1-2 cm Colorectal SSLs (NCT05117879)National Taiwan University Hospital2020-12-10
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients (NCT03945721)Massachusetts General Hospital2019-07-11
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer (NCT03384914)H. Lee Moffitt Cancer Center and Research Institute2018-02-19
Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis (NCT03093207)Universidade Estadual Paulista Júlio de Mesquita Filho2017-05-15
Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases (NCT03189576)Tampere University Hospital2015-10-01
Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant (NCT02389517)University of Chicago2015-03-02

Track Residual Disease automatically

Every clearance here is in the API, with alerts when new ones post.